+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Veterinary Oncology Market by Therapy (Chemotherapy, Immunotherapy, Radiology), Animal Type (Canine, Feline), Cancer Type - Forecast 2024-2030- Product Image
Global Veterinary Oncology Market by Therapy (Chemotherapy, Immunotherapy, Radiology), Animal Type (Canine, Feline), Cancer Type - Forecast 2024-2030- Product Image
Sale

Global Veterinary Oncology Market by Therapy (Chemotherapy, Immunotherapy, Radiology), Animal Type (Canine, Feline), Cancer Type - Forecast 2024-2030

  • PDF Icon

    Report

  • 182 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5305503
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Veterinary Oncology Market size was estimated at USD 390.30 million in 2023, USD 429.72 million in 2024, and is expected to grow at a CAGR of 10.24% to reach USD 772.77 million by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Veterinary Oncology Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Veterinary Oncology Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Veterinary Oncology Market, highlighting leading vendors and their innovative profiles. These include AB Science SA, Anivive Lifesciences, Ardent Animal Health, LLC, C.H. Boehringer Sohn AG & Ko. KG, Ceva Sante Animale S.A., Covetrus, Inc., Elanco Animal Health Incorporated, ELIAS Animal Health, Fidocure, IDEXX Laboratories, Inc., Karyopharm Therapeutics Inc., Leroy Biotech S.A.S., Morphogenesis, Inc., Nippon Zenyaku Kogyo Co., Ltd., PetCure Oncology LLC, PharmAust Limited, Regeneus Ltd., Rhizen Pharmaceuticals AG, Torigen Pharmaceuticals Inc., Varian Medical Systems, Inc., Vetco Pharmaceuticals Inc., VetDC, Inc., Vetoquinol S.A., Virbac SA, VolitionRx Limited, and Zoetis Inc.

Market Segmentation & Coverage

This research report categorizes the Veterinary Oncology Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Therapy
    • Chemotherapy
    • Immunotherapy
    • Radiology
    • Surgery
  • Animal Type
    • Canine
    • Feline
  • Cancer Type
    • Lymphoma
    • Mammary and Squamous Cell Cancer
    • Mast Cell Cancer
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Veterinary Oncology Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Veterinary Oncology Market?
  3. What are the technology trends and regulatory frameworks in the Veterinary Oncology Market?
  4. What is the market share of the leading vendors in the Veterinary Oncology Market?
  5. Which modes and strategic moves are suitable for entering the Veterinary Oncology Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Veterinary Oncology Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing Prevalence of Cancer in Pet Animals
5.1.1.2. Growing R&D Initiatives for Cancer Management
5.1.1.3. Technological Advancement in Pet Treatment
5.1.2. Restraints
5.1.2.1. High Cost of Pet Cancer Treatment
5.1.3. Opportunities
5.1.3.1. Rising Awareness Regarding Veterinary Cancer Therapies
5.1.3.2. Favourable Government Initiatives
5.1.4. Challenges
5.1.4.1. Adverse Effect of Drugs used for Pet Cancer Treatment
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Veterinary Oncology Market, by Therapy
6.1. Introduction
6.2. Chemotherapy
6.3. Immunotherapy
6.4. Radiology
6.5. Surgery
7. Veterinary Oncology Market, by Animal Type
7.1. Introduction
7.2. Canine
7.3. Feline
8. Veterinary Oncology Market, by Cancer Type
8.1. Introduction
8.2. Lymphoma
8.3. Mammary and Squamous Cell Cancer
8.4. Mast Cell Cancer
9. Americas Veterinary Oncology Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Veterinary Oncology Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Veterinary Oncology Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. AB Science SA
13.1.2. Anivive Lifesciences
13.1.3. Ardent Animal Health, LLC
13.1.4. C.H. Boehringer Sohn AG & Ko. KG
13.1.5. Ceva Sante Animale S.A.
13.1.6. Covetrus, Inc.
13.1.7. Elanco Animal Health Incorporated
13.1.8. ELIAS Animal Health
13.1.9. Fidocure
13.1.10. IDEXX Laboratories, Inc.
13.1.11. Karyopharm Therapeutics Inc.
13.1.12. Leroy Biotech S.A.S.
13.1.13. Morphogenesis, Inc.
13.1.14. Nippon Zenyaku Kogyo Co., Ltd.
13.1.15. PetCure Oncology LLC
13.1.16. PharmAust Limited
13.1.17. Regeneus Ltd.
13.1.18. Rhizen Pharmaceuticals AG
13.1.19. Torigen Pharmaceuticals Inc.
13.1.20. Varian Medical Systems, Inc.
13.1.21. Vetco Pharmaceuticals Inc.
13.1.22. VetDC, Inc.
13.1.23. Vetoquinol S.A.
13.1.24. Virbac SA
13.1.25. VolitionRx Limited
13.1.26. Zoetis Inc.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. VETERINARY ONCOLOGY MARKET RESEARCH PROCESS
FIGURE 2. VETERINARY ONCOLOGY MARKET SIZE, 2023 VS 2030
FIGURE 3. VETERINARY ONCOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. VETERINARY ONCOLOGY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. VETERINARY ONCOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. VETERINARY ONCOLOGY MARKET DYNAMICS
FIGURE 7. VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2023 VS 2030 (%)
FIGURE 8. VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2030 (%)
FIGURE 10. VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2023 VS 2030 (%)
FIGURE 12. VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. VETERINARY ONCOLOGY MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. VETERINARY ONCOLOGY MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. VETERINARY ONCOLOGY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. VETERINARY ONCOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 6. VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. VETERINARY ONCOLOGY MARKET SIZE, BY RADIOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. VETERINARY ONCOLOGY MARKET SIZE, BY SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 11. VETERINARY ONCOLOGY MARKET SIZE, BY CANINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. VETERINARY ONCOLOGY MARKET SIZE, BY FELINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 14. VETERINARY ONCOLOGY MARKET SIZE, BY LYMPHOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. VETERINARY ONCOLOGY MARKET SIZE, BY MAMMARY AND SQUAMOUS CELL CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. VETERINARY ONCOLOGY MARKET SIZE, BY MAST CELL CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 18. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 21. ARGENTINA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 22. ARGENTINA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 23. ARGENTINA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 24. BRAZIL VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 25. BRAZIL VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 26. BRAZIL VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 27. CANADA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 28. CANADA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 29. CANADA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 30. MEXICO VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 31. MEXICO VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 32. MEXICO VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 37. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 38. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 39. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 41. AUSTRALIA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 42. AUSTRALIA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 43. AUSTRALIA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 44. CHINA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 45. CHINA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 46. CHINA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 47. INDIA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 48. INDIA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 49. INDIA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 50. INDONESIA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 51. INDONESIA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 52. INDONESIA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 53. JAPAN VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 54. JAPAN VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 55. JAPAN VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 56. MALAYSIA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 57. MALAYSIA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 58. MALAYSIA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 59. PHILIPPINES VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 60. PHILIPPINES VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 61. PHILIPPINES VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 62. SINGAPORE VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 63. SINGAPORE VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 64. SINGAPORE VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 65. SOUTH KOREA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 66. SOUTH KOREA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 67. SOUTH KOREA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 68. TAIWAN VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 69. TAIWAN VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 70. TAIWAN VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 71. THAILAND VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 72. THAILAND VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 73. THAILAND VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 74. VIETNAM VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 75. VIETNAM VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 76. VIETNAM VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 81. DENMARK VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 82. DENMARK VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 83. DENMARK VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 84. EGYPT VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 85. EGYPT VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 86. EGYPT VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 87. FINLAND VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 88. FINLAND VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 89. FINLAND VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 90. FRANCE VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 91. FRANCE VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 92. FRANCE VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 93. GERMANY VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 94. GERMANY VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 95. GERMANY VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 96. ISRAEL VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 97. ISRAEL VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 98. ISRAEL VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 99. ITALY VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 100. ITALY VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 101. ITALY VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 102. NETHERLANDS VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 103. NETHERLANDS VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 104. NETHERLANDS VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 105. NIGERIA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 106. NIGERIA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 107. NIGERIA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 108. NORWAY VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 109. NORWAY VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 110. NORWAY VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 111. POLAND VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 112. POLAND VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 113. POLAND VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 114. QATAR VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 115. QATAR VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 116. QATAR VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 117. RUSSIA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 118. RUSSIA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 120. SAUDI ARABIA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 121. SAUDI ARABIA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 122. SAUDI ARABIA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 123. SOUTH AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 124. SOUTH AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 126. SPAIN VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 127. SPAIN VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 128. SPAIN VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 129. SWEDEN VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 130. SWEDEN VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 132. SWITZERLAND VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 133. SWITZERLAND VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 134. SWITZERLAND VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 135. TURKEY VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 136. TURKEY VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 137. TURKEY VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 138. UNITED ARAB EMIRATES VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 139. UNITED ARAB EMIRATES VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 140. UNITED ARAB EMIRATES VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 144. VETERINARY ONCOLOGY MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 145. VETERINARY ONCOLOGY MARKET SHARE, BY KEY PLAYER, 2023
TABLE 146. VETERINARY ONCOLOGY MARKET LICENSE & PRICING

Companies Mentioned

  • AB Science SA
  • Anivive Lifesciences
  • Ardent Animal Health, LLC
  • C.H. Boehringer Sohn AG & Ko. KG
  • Ceva Sante Animale S.A.
  • Covetrus, Inc.
  • Elanco Animal Health Incorporated
  • ELIAS Animal Health
  • Fidocure
  • IDEXX Laboratories, Inc.
  • Karyopharm Therapeutics Inc.
  • Leroy Biotech S.A.S.
  • Morphogenesis, Inc.
  • Nippon Zenyaku Kogyo Co., Ltd.
  • PetCure Oncology LLC
  • PharmAust Limited
  • Regeneus Ltd.
  • Rhizen Pharmaceuticals AG
  • Torigen Pharmaceuticals Inc.
  • Varian Medical Systems, Inc.
  • Vetco Pharmaceuticals Inc.
  • VetDC, Inc.
  • Vetoquinol S.A.
  • Virbac SA
  • VolitionRx Limited
  • Zoetis Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages182
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 429.72 Million
Forecasted Market Value ( USD ) by 2030 $ 772.77 Million
Compound Annual Growth Rate10.2%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Global Veterinary Oncology Market Size, Share & Trends Analysis Report by Therapy (Radiotherapy, Surgery), Animal Type (Canine, Feline), Cancer Type, Region, and Segment Forecasts, 2024-2030 - Product Image

Global Veterinary Oncology Market Size, Share & Trends Analysis Report by Therapy (Radiotherapy, Surgery), Animal Type (Canine, Feline), Cancer Type, Region, and Segment Forecasts, 2024-2030

  • Report
  • 130 Pages
  • Global
From
Veterinary Oncology Global Market Report 2024 - Product Image

Veterinary Oncology Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Global Veterinary Oncology Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis - Product Image

Global Veterinary Oncology Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

  • Report
  • 194 Pages
  • Global
From
Veterinary Oncology - Global Strategic Business Report - Product Image

Veterinary Oncology - Global Strategic Business Report

  • Report
  • 93 Pages
  • Global
From
North America Veterinary Oncology Market Size, Share & Trends Analysis Report By Animal Type (Canine, Feline), By Therapy (Radiotherapy, Surgery), By Cancer Type, By Country, And Segment Forecasts, 2023 - 2033 - Product Image

North America Veterinary Oncology Market Size, Share & Trends Analysis Report By Animal Type (Canine, Feline), By Therapy (Radiotherapy, Surgery), By Cancer Type, By Country, And Segment Forecasts, 2023 - 2033

  • Report
  • 150 Pages
  • North America
From

About the Market

Veterinary Oncology is a specialized field of veterinary medicine that focuses on the diagnosis and treatment of cancer in animals. Veterinary oncologists are trained to diagnose and treat a variety of cancers, including lymphoma, mast cell tumors, and bone cancer. Treatment options may include chemotherapy, radiation therapy, and surgery. Veterinary oncologists also provide supportive care to help animals cope with the side effects of cancer treatment. Veterinary oncology is an important part of animal healthcare, as cancer is a leading cause of death in animals. Veterinary oncologists work closely with other veterinary specialists, such as surgeons and radiologists, to provide comprehensive care for animals with cancer. Some companies in the Veterinary Oncology market include VetDC, VetCancer, and VetCure Oncology. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.